Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-16-000774
Filing Date
2016-08-08
Accepted
2016-08-05 18:51:22
Documents
24
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0729form10q.htm 10-Q 135258
2 EXHIBIT 31.1 skin0729form10qexh31_1.htm EX-31.1 8409
3 EXHIBIT 31.2 skin0729form10qexh31_2.htm EX-31.2 8428
4 EXHIBIT 32.1 skin0729form10qexh32_1.htm EX-32.1 4225
  Complete submission text file 0001554795-16-000774.txt   546324

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20160630.xml EX-101.INS 28122
6 XBRL SCHEMA FILE skin-20160630.xsd EX-101.SCH 6562
7 XBRL CALCULATION FILE skin-20160630_cal.xml EX-101.CAL 15635
8 XBRL DEFINITION FILE skin-20160630_def.xml EX-101.DEF 4571
9 XBRL LABEL FILE skin-20160630_lab.xml EX-101.LAB 59170
10 XBRL PRESENTATION FILE skin-20160630_pre.xml EX-101.PRE 40119
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 161812282
SIC: 6770 Blank Checks